General
South African variant of COVID-19 can ‘break through’ Pfizer vaccine, Israeli study says
The coronavirus variant discovered in South Africa can “break through” the Pfizer COVID-19 vaccine to some extent, a real-world data study in Israel has found, though its prevalence in the country is low and the research has not been peer reviewed.
Key points:
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease.
It matched age and gender, among other characteristics.
The South African variant, B.1.351, was found to make up about 1 per cent of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest…
-
Noosa News19 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News20 hours agoBrisbane-bound traffic diverted after pile-ups along Bruce Highway
-
Noosa News19 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General17 hours agoSummah Richards, 12, mourned after fatal e-scooter in Laidley, Queensland